Cannabis & Cannabinoids at AAAP 37th Annual Meeting and Scientific Symposium

17 sessions on cannabis & cannabinoids · November 12–15, 2026, Memphis, TN. Compare cannabis & cannabinoids at other meetings →

Saturday, November 14

08:45–10:25 · Symposium
Symposium III - Beyond Abstinence: Measuring What Matters in Cannabis Use Disorder Medication Development
Christina Brezing · Frances Levin · Margaret Haney · John Mariani
Discusses moving cannabis use disorder trials and clinical care from abstinence-only endpoints toward reduction-based, patient-centered outcome measures.
Drug Pipeline & Clinical Trials · Substance Use Disorders

Cannabis Use and Psychosis: A Case Series Highlighting Risk Factors for Schizophrenia-Spectrum Disorders. — Emily Waller
Association between Cannabis-Related Disorders and Incident Psychosis in Individuals with Adhd — Christian Nolan
Cannabis Withdrawal Symptoms Can Occur Rapidly, be Severe and Bothersome, and Lead to Relapse in Daily/Near Daily Cannabis Users: Results of a Quantitative Cannabis User Survey — Shelli Graham
Childhood Trauma and Motives for Cannabis Use in Individuals with Psychosis — Yousef Khan
High-Potency Cannabis as a Modifiable Risk Factor for Cannabis-Induced Psychosis in Adolescents and Young Adults — Sophia Azmi
Contingency Management for Cannabis Use during Pregnancy: A Narrative Review. — Olamide Idowu
Impact of Cannabis Legalization on Emergency Department Visits, Cannabis-Induced Psychosis, and Psychiatric Outcomes: A Community Hospital Analysis — Jaskaran Singh
Effect of Tetrahydrocannabinol on Neural Reward Receipt in Young Adult Cannabis Users: A Randomized, Placebo-Controlled Study — Dominic Grisafe
Posttraumatic Stress Symptoms, Medical Cannabis, and Pain Outcomes among Adults Prescribed Opioids — Sean Lynch
Medical Cannabis Knowledge and Clinical Readiness Among U.S. Medical Students — Nana Yaw Siriboe
Recurrent Cannabis Withdrawal-Associated Psychosis: A Case Report — Itamar Shapira
Legal, Intoxicating and Safe: A Pre-Prohibition Content Analysis of Hemp-Derived Novel Cannabinoid Marketing — Muhammad Youshay Jawad

Symposium · Symposia
Beyond Abstinence: Measuring What Matters in Cannabis Use Disorder Medication Development
Christina Brezing · Frances Levin · Margaret Haney · John Mariani
Argues for moving beyond abstinence as the sole endpoint in cannabis use disorder trials, discussing reduction-based and patient-centered outcome measures.
Drug Pipeline & Clinical Trials · Substance Use Disorders
Workshop · Workshops
Anyone Can Treat! Building Confidence in Treating Youth Cannabis Use Disorder
Gerald Busch · Ravi Shankar · Cathryn A. Galanter
Builds general clinicians' confidence and skills in treating cannabis use disorder in adolescents.
Child & Adolescent · Substance Use Disorders
Workshop · Workshops
From Plant to Patient: Navigating the Evidence, Risks, and Counseling of Medical Cannabis
Elizabeth McCord · Yilang Tang · Karen Drexler · Michael Hsu
Reviews the evidence base, risks, and patient-counseling approaches surrounding medical cannabis.
Workshop · Workshops
What Are You Smoking?: Addressing Nicotine and Cannabis Use in Adolescents
Jennifer Creedon · Britney Lambert · Kimberly Rousseau
Assessment and treatment strategies for nicotine and cannabis use among adolescents.
Child & Adolescent · Substance Use Disorders